Search Results
Treatment Approaches in Renal Cancer Global Evaluation Trial. J Clin Oncol. 2009; 27: 3312–3318. 11 Motzer RJ, Hutson TE, Tomczak P, et al. Overall survival and updated results for
leiomyomatosis, hereditary leiomyomatosis and renal cancer and fumarate hydratase deficiency. Hum. Mol. Genet., 2003, 12 (11), 1241–1252. Zavadil, J., Ye, H., Liu, Z., et al.: Profiling and functional analyses of microRNAs
, R., Glenn, L., Hoen, H., et al.: Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program. J. Immunother. Cancer, 2014, 2, 13
proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. Cancer Res. 63, 6971–6983 (2003) Rogers M
prolonging the time to renal cancer surgery affect long-term cancer control: a systematic review of the literature. Can J Urol. 2006; 13 (Suppl 3): 54–61. 61 Bell D, Morash C
renal cancer antigen through post-translational protein splicing. Nature 427 , 252–256 (2004). Yang JC Immune recognition of a human renal cancer antigen through post
Kirchner, H. H., Anton, P., Atzpodien, J.: Adjuvant treatment of locally advanced renal cancer with autologous virus-modified tumor vaccine. World J Urol 13 , 171 (1995). Adjuvant treatment of locally advanced renal cancer with
L Haworth RM Sherry 2003 A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal
